Clinical trials: Insulin Dependent Diabetes
Diabetes Mellitus, Type 1
Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 Diabetes
Background: Patients with type 1 diabetes (T1D) need a lifelong supply of external insulin and are advised to aim for near-normalization of blood glucose levels through intensive insulin therapy.
- Trial name
- GluST1 (NCT02232971)
- Testing
- Glucagon, Isotonic saline solution
- Where
- Denmark
- Volunteers
- 8 people
- Sponsor
- Hvidovre University Hospital
Type 1 Diabetes
Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening
This study aims at quantifying the accuracy of a self-administered fingerstick based glucose tolerance test (GTT@Home) respect to the gold-standard in-clinic venous plasma measures during the oral glucose tolerance test (OGTT)…
- Trial name
- NCT07155252
- Testing
- GTT@Home
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Yale University
Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus (T1DM)
Pediatric Insulin Plan Calculator for T1DM Management
This is a multi-centre, prospective, randomized, open-label controlled trial designed to evaluate the effectiveness of a flexible digital insulin dose calculator in children under 12 years of age with Type 1 Diabetes Mellitus…
- Conditions
- Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus (T1DM), T1DM, T1DM - Type 1 Diabetes Mellitus
- Trial name
- FLEXI-T1D (NCT07427134)
- Testing
- Flexible Digital Insulin Dose Calculator
- Where
- 2 sites in Iraq, Pakistan
- Volunteers
- 440 people
- Sponsor
- Sultan Qaboos University
Type 1 Diabetes
New Strategies for Postprandial Glycemic Control Using Insulin Pump Therapy
Achieving near-normoglycemia has been established as the main objective for most patients with type 1 diabetes (T1DM). However, insulin dosing is an empirical process and its success is highly dependent on the patients' and…
- Trial name
- NCT01550809
- Testing
- iBolus, tBolus (traditional bolus)
- Where
- Spain
- Volunteers
- 12 people
- Sponsor
- Fundación para la Investigación del Hospital Clínico de Valencia
Type 1 Diabetes
A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes
The investigators aim to assess the glycemic outcomes of a fully automated insulin-and-pramlintide artificial pancreas and a comparator insulin-alone artificial pancreas with carbohydrate matched boluses.
- Trial name
- FCL (NCT05199714)
- Testing
- Fiasp, Artificial Pancreas, Pramlintide
- Where
- Canada
- Volunteers
- 12 people
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
Diabetic Nephropathy.
SLC2A1 Variants and Diabetic Nephropathy
Cells damaged by hyperglycemia are unable to downregulate glucose entrance in presence of high extracellular glucose resulting in intracellular activation of deleterious biochemical pathways.
- Trial name
- NCT01768611
- Where
- Brazil
- Volunteers
- 449 people
- Sponsor
- University of Sao Paulo General Hospital
Type 1 Diabetes Mellitus, Peripheral Artery Disease
Clinical Features and Prevalence of Asymptomatic Peripheral Artery Disease in Patients With Type 1 Diabetes Mellitus
AIMS: Determining the clinical features and prevalence of peripheral artery disease (PAD) in asymptomatics patients with type 1 diabetes mellitus (T1DM) and checking the validity of the current recommendations regarding for PAD…
- Trial name
- NCT02910271
- Where
- Spain
- Volunteers
- 299 people
- Sponsor
- Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Type 1 Diabetes
Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes
Patients with type 1 diabetes trained in multiple daily insulin injection were treated with two diffferent kinds of long acting insulin preparations. The two insulin preparations were glargine and ultralente insulin.
- Trial name
- NCT00276393
- Testing
- Basal insulin
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- Mayo Clinic
Type 1 Diabetes Mellitus
Effect of Ambient Temperature on Blood Glucose and Insulin Absorption in Adults With Type 1 Diabetes
The goal of this clinical trial is to learn how different temperatures affect blood sugar levels in adults with type 1 diabetes.
- Trial name
- T1Temp (NCT07491133)
- Testing
- Environmental Temperature Exposure
- Where
- Canada
- Volunteers
- 30 people
- Sponsor
- Institut de Recherches Cliniques de Montreal
Diabetes, Type I, Enterovirus Infections
Diabetes Virus Detection Project, Intervention With GAD-alum
The purposes of this study are to test whether GAD vaccination can stop the progression of newly diagnosed type 1 diabetes, to describe the related immunological processes (insulitis) in pancreas and small intestines evolving the…
- Conditions
- Diabetes, Type I, Enterovirus Infections, Autoimmunity
- Trial name
- DiViD (NCT01129232)
- Testing
- GAD-alum
- Where
- Norway
- Volunteers
- 6 people
- Sponsor
- Oslo University Hospital
Type 1 Diabetes
Assessing Continuous Non- Invasive Blood Glucose Sensor- Physical Logic AG
The present study is aimed to evaluate the feasibility of a new noninvasive method to measure continuous glucose values using electromagnetic radiation.
- Trial name
- NCT01247649
- Testing
- Physical Logic Continuous Glucose Monitoring System
- Where
- Israel
- Volunteers
- 4 people
- Sponsor
- Rabin Medical Center
Type 1 Diabetes Mellitus
An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes (INNODIA)
INNODIA is a global consortium linking 26 academic institutions, 4 industrial partners, a small to medium enterprise (SME), and 2 patient organisations, bringing their knowledge and experience together with one common goal: "To…
- Trial name
- INNODIA (NCT03936634)
- Where
- 19 sites in Austria, Belgium and 11 more
- Volunteers
- 6,000 people, healthy volunteers welcome
- Sponsor
- University of Cambridge
Type1 Diabetes Mellitus
DiabetesFlex - Patient Involvement and Patient-reported Outcome Measures in Type 1 Diabetes
The aim of this study is to investigate the effect of the use of DiabetesFlex in diabetes care compared to standard care in relation to patient involvement and relevance for specific group of persons with T1DM.
- Trial name
- NCT03202732
- Testing
- DiabetesFlex
- Where
- Denmark
- Volunteers
- 344 people
- Sponsor
- Annesofie Lunde Jensen
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS
Hypoglycaemia or low blood glucose, and its fear are major barriers to achieving optimal glucose control. New technology, such as continuous glucose monitors (CGM), help to better identify hypoglycaemia and develop strategies to…
- Conditions
- Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Hypoglycemia, Hypoglycemia Unawareness
- Trial name
- Hypo-METRICS (NCT04304963)
- Testing
- NO intervention - observational study
- Where
- United Kingdom
- Volunteers
- 602 people
- Sponsor
- King's College London
Non-Alcoholic Fatty Liver Disease, Glucagon Resistance
Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic Steatosis
Glucagon is secreted from pancreatic alpha-cells in response to protein-rich meals and during hypoglycemia. A physiological feedback system exists between the liver and the pancreatic alpha cells termed the liver-alpha cell axis…
- Conditions
- Non-Alcoholic Fatty Liver Disease, Glucagon Resistance, Type 1 Diabetes, Obesity
- Trial name
- GLUSENTIC (NCT04907721)
- Testing
- Glucagon Sensitivity test consisting of an amino acid tolerance test and a bolus infusion of glucagon
- Where
- Denmark
- Volunteers
- 65 people, healthy volunteers welcome
- Sponsor
- University of Copenhagen
Cardiovascular Diseases, Coronary Disease
Lifestyle Management for Women With CHD and NIDDM
To develop and evaluate a comprehensive lifestyle self-management (CLSM) program (low-fat vegetarian diet, smoking cessation and stress management training) for postmenopausal women with coronary heart disease and Type II…
- Conditions
- Cardiovascular Diseases, Coronary Disease, Heart Diseases, Diabetes Mellitus, Non-insulin Dependent
- Trial name
- NCT00005441
- Sponsor
- Oregon Research Institute
Type 2 Diabetes Mellitus
GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes
Investigation of GIP effects at fasting and hypoglycemia
- Trial name
- GIP-HYPO-T2DM (NCT01414556)
- Testing
- Glucose-dependent Insulinotropic polypeptide, saline
- Where
- Denmark
- Volunteers
- 12 people
- Sponsor
- Mikkel Christensen
Diabetes Mellitus, Type 1
Testing an Integrated Care Model Trial
This study aims to test the use of an adapted collaborative care model for improving the health outcomes of adults diagnosed with type 1 diabetes (T1D). The duration of the study is 18 months with 4 study survey points.
- Trial name
- NCT06448429
- Testing
- Usual care, Collaborative care model (CoCM)
- Where
- United States
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Emory University
Type 1 Diabetes Mellitus
The Advisor Pro Direct Study
The DreaMed Advisor Pro is a software which automatically analyses treatment information, learns patient's needs and accordingly suggests adjustments in insulin dosing.
- Trial name
- NCT03774069
- Testing
- DreaMed Advisor Pro, Medical guided recommendation
- Where
- Israel
- Volunteers
- 100 people
- Sponsor
- Rabin Medical Center
Diabetes Mellitus, Type 1
Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation
This is a Phase II open, randomized, active comparator-controlled multi center study in patients with severe type-1 diabetes. This is a two-armed study where patients are randomized in a 2:1 ratio between IBsolvMIR and heparin.
- Trial name
- NCT03867851
- Testing
- IBsolvMIR, Heparin
- Where
- 5 sites in Netherlands, Norway and 1 more
- Volunteers
- 7 people
- Sponsor
- TikoMed AB
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.